Vitamin Shoppe (VSI) 10-Q 4 Nov 15 2015 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 26, 2015	Oct. 16, 2015
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 26, 2015
Document Fiscal Year Focus	2,015
Document Fiscal Period Focus	Q3
Trading Symbol	VSI
Entity Registrant Name	Vitamin Shoppe, Inc.
Entity Central Index Key	1,360,530
Current Fiscal Year End Date	--12-26
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		29,120,557

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 26, 2015	Dec. 27, 2014
Current assets:
Cash and cash equivalents	$ 1,981	$ 12,166
Accounts receivable, net of allowance of $973 and $1,883 in 2015 and 2014, respectively	5,065	10,376
Inventories	218,096	187,027
Prepaid expenses and other current assets	37,391	37,029
Total current assets	262,533	246,598
Property and equipment, net of accumulated depreciation and amortization of $263,878 and $238,613 in 2015 and 2014, respectively	139,701	140,596
Goodwill	243,269	243,269
Other intangibles, net	87,824	89,025
Other assets	2,937	2,903
Total assets	736,264	722,391
Current liabilities:
Revolving credit facility	8,000	8,000
Accounts payable	44,008	37,396
Accrued expenses and other current liabilities	65,497	75,820
Total current liabilities	117,505	121,216
Deferred income taxes	12,472	9,151
Deferred rent	40,458	39,388
Other long-term liabilities	$ 627	$ 702
Commitments and contingencies
Stockholders' equity:
Preferred stock, $0.01 par value; 250,000,000 shares authorized and no shares issued and outstanding at September 26, 2015 and December 27, 2014
Common stock, $0.01 par value; 400,000,000 shares authorized, 29,233,983 shares issued and 29,115,012 shares outstanding at September 26, 2015, and 30,106,337 shares issued and 30,048,881 shares outstanding at December 27, 2014	$ 292	$ 301
Additional paid-in capital	235,839	267,083
Treasury stock, at cost; 118,971 shares at September 26, 2015 and 57,456 shares at December 27, 2014	(5,187)	(2,695)
Accumulated other comprehensive loss	(109)	(83)
Retained earnings	334,367	287,328
Total stockholders' equity	565,202	551,934
Total liabilities and stockholders' equity	$ 736,264	$ 722,391

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Sep. 26, 2015	Dec. 27, 2014
Statement of Financial Position [Abstract]
Accounts receivable, allowances	$ 973	$ 1,883
Accumulated depreciation and amortization, property and equipment	$ 263,878	$ 238,613
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, shares authorized	250,000,000	250,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	400,000,000	400,000,000
Common stock, shares issued	29,233,983	30,106,337
Common stock, shares outstanding	29,115,012	30,048,881
Treasury stock, shares	118,971	57,456

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 26, 2015	Sep. 27, 2014	Sep. 26, 2015	Sep. 27, 2014
Income Statement [Abstract]
Net sales	$ 313,886	$ 308,910	$ 973,059	$ 922,964
Cost of goods sold	209,177	211,616	645,441	613,294
Gross profit	104,709	97,294	327,618	309,670
Selling, general and administrative expenses	81,352	76,745	249,742	226,708
Income from operations	23,357	20,549	77,876	82,962
Interest expense, net	172	140	515	325
Income before provision for income taxes	23,185	20,409	77,361	82,637
Provision for income taxes	9,087	8,212	30,322	33,005
Net income	$ 14,098	$ 12,197	$ 47,039	$ 49,632
Weighted average common shares outstanding
Basic	28,988,779	30,332,506	29,238,808	30,327,800
Diluted	29,190,454	30,710,564	29,504,418	30,767,854
Net income per common share
Basic	$ 0.49	$ 0.40	$ 1.61	$ 1.64
Diluted	$ 0.48	$ 0.40	$ 1.59	$ 1.61

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 26, 2015	Sep. 27, 2014	Sep. 26, 2015	Sep. 27, 2014
Condensed Consolidated Statements Of Comprehensive Income [Abstract]
Net income	$ 14,098	$ 12,197	$ 47,039	$ 49,632
Other comprehensive loss:
Foreign currency translation adjustments	(85)	(1)	(26)	(17)
Other comprehensive loss	(85)	(1)	(26)	(17)
Comprehensive income	$ 14,013	$ 12,196	$ 47,013	$ 49,615

Condensed Consolidated Stateme6

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 26, 2015	Sep. 27, 2014
Cash flows from operating activities:
Net income	$ 47,039	$ 49,632
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization of fixed and intangible assets	28,457	25,060
Impairment charge on fixed assets	321
Amortization of deferred financing fees	141	104
Deferred income taxes	3,248	3,892
Deferred rent	(1,708)	(171)
Equity compensation expense	4,716	5,761
Tax benefits on exercises of equity awards	71	(4,832)
Changes in operating assets and liabilities:
Accounts receivable	5,311	1,770
Inventories	(29,911)	(7,458)
Prepaid expenses and other current assets	(786)	(10,878)
Other assets	(221)	2,465
Accounts payable	1,292	(10,919)
Accrued expenses and other current liabilities	(3,087)	8,904
Other long-term liabilities	2,726	5,829
Net cash provided by operating activities	56,650	69,159
Cash flows from investing activities:
Capital expenditures	(30,172)	(30,801)
Trademarks and other intangible assets	(444)	(573)
Net cash used in investing activities	(30,129)	(112,912)
Cash flows from financing activities:
Borrowings under revolving credit facility	27,000
Repayments of borrowings under revolving credit facility	(27,000)
Bank overdraft	5,822
Proceeds from exercises of common stock options	1,348	6,650
Issuance of shares under employee stock purchase plan	718	702
Tax benefits on exercises of equity awards	(71)	4,832
Purchases of treasury stock	(2,492)	(2,320)
Purchases of shares under Share Repurchase Program	(37,965)	(7,815)
Other financing activities	(97)	(182)
Net cash (used in) provided by financing activities	(36,778)	1,867
Effect of exchange rate changes on cash and cash equivalents	72	11
Net decrease in cash and cash equivalents	(10,185)	(41,875)
Cash and cash equivalents beginning of period	12,166	74,036
Cash and cash equivalents end of period	1,981	32,161
Supplemental disclosures of cash flow information:
Interest paid	282	175
Income taxes paid	26,351	30,012
Supplemental disclosures of non-cash investing activities:
Liability for purchases of property and equipment	5,617	9,149
FDC Vitamins, LLC [Member]
Adjustments to reconcile net income to net cash provided by operating activities:
Contingent consideration payment for FDC Vitamins, LLC acquisition	(959)
Cash flows from investing activities:
Acquisition of business	487	$ (81,538)
Cash flows from financing activities:
Contingent consideration payment for FDC Vitamins, LLC acquisition	$ (4,041)

Basis of Presentation

Basis of Presentation	9 Months Ended
	Sep. 26, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	1. Basis of Presentation Vitamin Shoppe, Inc. (“VSI”), is incorporated in the State of Delaware, and through its wholly-owned subsidiary, Vitamin Shoppe Industries Inc. (“Subsidiary” or “Industries” together with VSI, the “Company”), is a multi-channel specialty retailer and contract manufacturer of nutritional products. Sales of both national brands and our own brands of vitamins, minerals, herbs, specialty supplements, sports nutrition and other health and wellness products (“VMS products”) are made through VSI-operated retail stores, the internet and mail order catalogs to customers located primarily in the United States. In addition, the Company manufactures products for both sales to third parties as well as for the VSI product assortment. The condensed consolidated financial statements as of September 26, 2015 and for the three and nine months ended September 26, 2015 and September 27, 2014, are unaudited. The condensed consolidated balance sheet as of December 27, 2014 was derived from our audited financial statements. All intercompany transactions and balances have been eliminated in consolidation. In addition, certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) have been condensed or omitted. The interim financial statements reflect all adjustments, which are, in the opinion of management, necessary for a fair presentation in conformity with GAAP. The interim financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Form 10-K for the fiscal year ended December 27, 2014, as filed with the Securities and Exchange Commission on February 24, 2015 (the “Fiscal 2014 Form 10-K”). The results of operations for the interim periods should not be considered indicative of results to be expected for the full year. The Company’s fiscal year ends on the last Saturday in December. As used herein, the term “Fiscal Year” or “Fiscal” refers to a 52-week period, ending on the last Saturday in December. The results for the three and nine months ended September 26, 2015 and September 27, 2014, are each based on 13-week and 39-week periods, respectively. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosures of contingent assets and liabilities at the date of the financial statements, and revenue and expenses during the reporting period. Actual results could differ from those estimates. Except as noted below, the Company has considered all new accounting pronouncements and has concluded that there are no new pronouncements that may have a material impact on its results of operations, financial condition, or cash flows, based on current information. In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update No. 2014-09 (“ASU 2014-09”), Revenue from Contracts with Customers (Topic 606). Under ASU 2014-09, an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In July 2015, the FASB deferred the effective date of ASU 2014-09 by one year. As a result of this deferral, ASU 2014-09 will be effective for annual reporting periods beginning after December 15, 2017 for public companies and early adoption of ASU 2014-09 is permitted for public companies for annual reporting periods beginning after December 15, 2016. The Company is evaluating ASU 2014-09 to determine if this guidance will have a material impact on the Company’s condensed consolidated financial statements. In July 2015, the FASB issued Accounting Standards Update No. 2015-11 (“ASU 2015-11”), Simplifying the Measurement of Inventory (Topic 330). ASU 2015-11 simplifies the subsequent measurement of inventory by requiring inventory to be measured at the lower of cost and net realizable value. Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. ASU 2015-11 is effective for public companies for annual reporting periods beginning after December 15, 2016, and interim periods within those fiscal years. Early adoption of ASU 2015-11 is permitted. The Company is evaluating ASU 2015-11 to determine if this guidance will have a material impact on the Company’s condensed consolidated financial statements.

Acquisition

Acquisition	9 Months Ended
	Sep. 26, 2015
Business Combinations [Abstract]
Acquisition	2. Acquisition On June 6, 2014, the Company acquired all of the outstanding equity interests of FDC Vitamins, LLC d/b/a Nutri-Force Nutrition (“Nutri-Force”), a company which provides custom manufacturing and private labeling of vitamins, dietary supplements, nutraceuticals and nutritional supplements, as well as, develops and markets its own branded products. The total purchase price was $86.1 million in cash, which includes $5.0 million of contingent consideration which was paid in Fiscal 2015. See Note 12. Segment Data for additional information.

Inventories

Inventories	9 Months Ended
	Sep. 26, 2015
Inventory Disclosure [Abstract]
Inventories	3. Inventories The components of inventories are as follows (in thousands): September 26, December 27, Finished goods $ 197,145 $ 171,896 Work-in-process 7,126 4,592 Raw materials 13,825 10,539 $ 218,096 $ 187,027

Goodwill and Intangible Assets

Goodwill and Intangible Assets	9 Months Ended
	Sep. 26, 2015
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	4. Goodwill and Intangible Assets Goodwill is allocated between the Company’s segments (reporting units), retail, direct and manufacturing. The following table discloses the carrying value of all intangible assets (in thousands): September 26, 2015 December 27, 2014 Gross Accumulated Net Gross Accumulated Net Intangible assets Goodwill $ 243,269 $ — $ 243,269 $ 243,269 $ — $ 243,269 Tradenames – Indefinite-lived 68,405 — 68,405 68,405 — 68,405 Brands 10,000 741 9,259 10,000 324 9,676 Customer relationships 7,500 500 7,000 7,500 219 7,281 Tradenames – Definite-lived 4,693 2,486 2,207 4,250 1,735 2,515 Software 1,300 347 953 1,300 152 1,148 Intangibles related to asset purchase — — — 2,950 2,950 — $ 335,167 $ 4,074 $ 331,093 $ 337,674 $ 5,380 $ 332,294 The useful lives of the Company’s definite-lived intangible assets are between 3 to 20 years. The expected amortization expense on definite-lived intangible assets on the Company’s condensed consolidated balance sheet at September 26, 2015, is as follows (in thousands): Remainder of Fiscal 2015 $ 555 Fiscal 2016 1,515 Fiscal 2017 1,420 Fiscal 2018 1,420 Fiscal 2019 1,265 Thereafter 13,244 $ 19,419

Accrued Expenses and Other Curr

Accrued Expenses and Other Current Liabilities	9 Months Ended
	Sep. 26, 2015
Payables and Accruals [Abstract]
Accrued Expenses and Other Current Liabilities	5. Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consist of the following (in thousands): September 26, December 27, Deferred sales $ 16,909 $ 22,499 Accrued salaries and related expenses (1) 11,109 8,824 Sales tax payable and related expenses 7,453 6,494 Accrued fixed asset additions 5,052 7,290 Other accrued expenses 24,974 30,713 $ 65,497 $ 75,820 (1) Accrued salaries and related expenses as of September 26, 2015 includes $1.2 million related to accrued employee severance.

Credit Arrangements

Credit Arrangements	9 Months Ended
	Sep. 26, 2015
Debt Disclosure [Abstract]
Credit Arrangements	6. Credit Arrangements As of September 26, 2015 and December 27, 2014, the Company had $8.0 million of borrowings outstanding on its Revolving Credit Facility. Revolving Credit Facility Subject to the terms of the Revolving Credit Facility, which has a maturity date of October 11, 2018, the Company may borrow up to $90.0 million, with a Company option to increase the facility up to a total of $150.0 million. The availability under the Revolving Credit Facility is subject to a borrowing base calculated on the value of certain accounts receivable as well as certain inventory of the Company. The obligations thereunder are secured by a security interest in substantially all of the assets of the Company. Under the Revolving Credit Facility, VSI has guaranteed the Company’s obligations, and Industries and its wholly-owned subsidiaries have each guaranteed the obligations of the other respective entities. The Revolving Credit Facility provides for affirmative and negative covenants affecting the Company. The Revolving Credit Facility restricts, among other things, the Company’s ability to incur indebtedness, create or permit liens on the Company’s assets, declare or pay dividends and make certain other restricted payments, consolidate, merge or recapitalize, sell assets, make certain investments, loans or other advances, enter into transactions with affiliates, change our line of business, and restricts the types of hedging activities the Company can enter into. The largest amount borrowed during the nine months ended September 26, 2015 was $27.0 million. There were no borrowings during the nine months ended September 27, 2014. The unused available line of credit under the Revolving Credit Facility at September 26, 2015 was $79.2 million. Borrowings under the Revolving Credit Facility accrue interest, at the Company’s option, at the rate per annum based on an “alternative base rate” plus 0.25% or 0.50% or the adjusted Eurodollar rate plus 1.25% or 1.50%, in each case with the higher spread applicable in the event that the aggregate amount of the borrowings under the Revolving Credit Facility exceeds 50% of the borrowing base availability under the Revolving Credit Facility. The weighted average interest rate for the Revolving Credit Facility during the nine months ended September 26, 2015 was 1.44%. The commitment fee on the undrawn portion of the $90.0 million Revolving Credit Facility was 0.25% as of September 26, 2015 and December 27, 2014. Interest expense, net for the three and nine months ended September 26, 2015 and September 27, 2014 consists of the following (in thousands): Three Months Ended Nine Months Ended September 26, September 27, September 26, September 27, Fees on the revolving credit facility and interest $ 110 $ 103 $ 375 $ 234 Amortization of deferred financing fees 62 37 141 104 Interest income — — (1 ) (13 ) Interest expense, net $ 172 $ 140 $ 515 $ 325

Stock Based Compensation

Stock Based Compensation	9 Months Ended
	Sep. 26, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock Based Compensation	7. Stock Based Compensation Equity Incentive Plans – The following table summarizes restricted shares for the 2009 Plan as of September 26, 2015 and changes during the nine month period then ended: Number of Unvested Weighted Unvested at December 27, 2014 448,611 $ 45.04 Granted 220,831 $ 40.71 Vested (153,493 ) $ 42.95 Canceled/forfeited (116,778 ) $ 45.09 Unvested at September 26, 2015 399,171 $ 43.43 The total intrinsic value of restricted shares vested during the nine months ended September 26, 2015 and September 27, 2014, was $6.2 million and $5.3 million, respectively. The following table summarizes stock options for the 2006 and 2009 Plans as of September 26, 2015 and changes during the nine month period then ended: Number Weighted Weighted Aggregate Outstanding at December 27, 2014 383,577 $ 24.14 Granted — — Exercised (56,338 ) $ 23.93 Canceled/forfeited (39,792 ) $ 34.43 Outstanding at September 26, 2015 287,447 $ 22.75 3.14 $ 3,442 Vested or expected to vest at September 26, 2015 287,165 $ 22.75 3.14 Vested and exercisable at September 26, 2015 284,630 $ 22.45 3.10 $ 3,442 The total intrinsic value of options exercised during the nine months ended September 26, 2015 and September 27, 2014, was $1.0 million and $13.3 million, respectively. The cash received from options exercised during the nine months ended September 26, 2015 and September 27, 2014 was $1.3 million and $6.7 million, respectively. The following table summarizes restricted share units for the 2009 Plan as of September 26, 2015 and changes during the nine month period then ended: Number of Unvested Weighted Unvested at December 27, 2014 9,633 $ 51.37 Granted 20,747 $ 39.99 Vested (14,995 ) $ 49.99 Canceled/forfeited — — Unvested at September 26, 2015 15,385 $ 37.37 The total intrinsic value of restricted share units vested during the nine months ended September 26, 2015 and September 27, 2014, was $0.5 million and $0.3 million, respectively. Compensation expense attributable to stock based compensation for the three and nine months ended September 26, 2015 was approximately $1.2 million and $4.7 million, respectively, and for the three and nine months ended September 27, 2014 was approximately $2.0 million and $5.8 million, respectively. As of September 26, 2015, the remaining unrecognized stock based compensation expense for non-vested stock options, restricted shares and restricted share units to be expensed in future periods is $9.6 million, and the related weighted-average period over which it is expected to be recognized is 1.7 years. Forfeitures are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The Company estimates forfeitures based on its historical forfeiture rate since the inception of granting stock based awards. The estimated value of future forfeitures for stock options, restricted shares and restricted share units as of September 26, 2015 is approximately $0.9 million. The weighted-average grant date fair value of stock options during the three and nine months ended September 27, 2014 was $9.63 and $18.99, respectively. These valuations represent the fair value of subsequent annual tranches of performance based stock options granted in 2011, and there were no such valuations during the three and nine months ended September 26, 2015. The fair value of each option grant was estimated on the date of grant using the Black-Scholes option-pricing model with the following assumptions: Three Months Ended Nine Months Ended September 27, 2014 September 27, 2014 Expected dividend yield 0.0 % 0.0 % Weighted average expected volatility 33.3 % 35.3 % Weighted average risk-free interest rate 1.4 % 1.4 % Expected holding period 4.00 years 4.00 - 4.43 years Treasury Stock

Advertising Costs

Advertising Costs	9 Months Ended
	Sep. 26, 2015
Text Block [Abstract]
Advertising Costs	8. Advertising Costs The costs of advertising for online marketing arrangements, magazines, direct mail, television and radio are expensed the first time the advertising takes place. Costs associated with the production and distribution of the Company’s catalogs are expensed as incurred. Advertising expense was $5.3 million for the three months ended September 26, 2015 and September 27, 2014, and $16.8 million and $15.3 million for the nine months ended September 26, 2015 and September 27, 2014, respectively.

Net Income Per Share

Net Income Per Share	9 Months Ended
	Sep. 26, 2015
Earnings Per Share [Abstract]
Net Income Per Share	9. Net Income Per Share The Company’s basic net income per share excludes the dilutive effect of stock options, unvested restricted shares and unvested restricted share units. It is based upon the weighted average number of common shares outstanding during the period divided into net income. Diluted net income per share reflects the potential dilution that would occur if securities or other contracts to issue common stock were exercised or converted into common stock. Stock options, unvested restricted shares and unvested restricted share units are included as potential dilutive securities for the periods applicable, using the treasury stock method to the extent dilutive. The components of the calculation of basic net income per common share and diluted net income per common share are as follows (in thousands except share and per share data): Three Months Ended Nine Months Ended September 26, September 27, September 26, September 27, Numerator: Net income $ 14,098 $ 12,197 $ 47,039 $ 49,632 Denominator: Basic weighted average common shares outstanding 28,988,779 30,332,506 29,238,808 30,327,800 Effect of dilutive securities: Stock options 86,627 207,871 103,885 261,996 Restricted shares 113,535 164,355 160,252 174,515 Restricted share units 1,513 5,832 1,473 3,543 Diluted weighted average common shares outstanding 29,190,454 30,710,564 29,504,418 30,767,854 Basic net income per common share $ 0.49 $ 0.40 $ 1.61 $ 1.64 Diluted net income per common share $ 0.48 $ 0.40 $ 1.59 $ 1.61 Stock options and restricted shares for the three months ended September 26, 2015 and September 27, 2014 in the amount of 90,737 shares and 8,355 shares, respectively, have been excluded from the above calculation as they were anti-dilutive. Stock options and restricted shares for the nine months ended September 26, 2015 and September 27, 2014 in the amount of 34,803 shares and 17,450 shares, respectively, have been excluded from the above calculation as they were anti-dilutive.

Share Repurchase Programs

Share Repurchase Programs	9 Months Ended
	Sep. 26, 2015
Equity [Abstract]
Share Repurchase Programs	10. Share Repurchase Programs On each of August 5, 2014 and May 6, 2015, the Company’s board of directors approved share repurchase programs that enable the Company to purchase up to $100 million, for a total of up to $200 million, of its shares of common stock from time to time over three year periods ending on August 4, 2017 and May 5, 2018, respectively. As of September 26, 2015, 2,253,392 shares have been repurchased pursuant to these programs for a total of $95.8 million. The repurchase programs do not obligate the Company to acquire any specific number of shares of its common stock and may be suspended, terminated or modified at any time for any reason, including market conditions, the cost of repurchasing such shares, the availability of alternative investment opportunities, liquidity, and other factors. These factors may also affect the timing and amount of share repurchases. During the three and nine months ended September 26, 2015, the Company repurchased 355,021 and 981,353 shares, respectively, of its common stock in the open market, which were retired upon repurchase. The total purchase price during the three and nine months ended September 26, 2015 was $12.4 million and $38.0 million, respectively, with an average repurchase price per share of $35.00 and $38.69, respectively.

Legal Proceedings

Legal Proceedings	9 Months Ended
	Sep. 26, 2015
Commitments and Contingencies Disclosure [Abstract]
Legal Proceedings	11. Legal Proceedings The Company is party to various lawsuits arising from time to time in the normal course of business, some of which are covered by insurance. Although the impact of the final resolution of these matters on the Company’s financial condition, results of operations or cash flows is not known, management does not believe that the resolution of these lawsuits will have a material adverse effect on the financial condition, results of operations or liquidity of the Company.

Segment Data

Segment Data	9 Months Ended
	Sep. 26, 2015
Segment Reporting [Abstract]
Segment Data	12. Segment Data The Company currently operates three business segments, retail, direct and manufacturing. The operating segments are segments of the Company for which separate financial information is available and for which operating results are evaluated regularly by executive management in deciding how to allocate resources and in assessing performance. The Company’s management evaluates segment operating results based on several indicators. The primary key performance indicators are sales and operating income for each segment. The table below represents key financial information for each of the Company’s business segments as well as corporate costs. The retail segment primarily includes the Company’s retail stores. The retail segment generates revenue primarily through the sale of VMS products through Vitamin Shoppe, Super Supplements and Vitapath retail stores in the United States, Puerto Rico and in Canada. The direct segment generates revenue through the sale of VMS products primarily through the Company’s websites and catalog. The Company’s websites offer customers online access to a full assortment of approximately 21,500 SKUs. The manufacturing segment supplies the retail and direct segments, along with various thirds parties, with finished products for sale. Corporate costs represent all other expenses not allocated to the retail, direct or manufacturing segments which include, but are not limited to: human resources, legal, retail management, direct management, finance, information technology, depreciation (primarily related to assets utilized by the retail and direct business segments as well as corporate assets) and amortization, and various other corporate level activity related expenses. Intercompany sales transactions are eliminated in consolidation. The Company’s segments are designed to allocate resources internally and provide a framework to determine management responsibility. The accounting policies of the segments are consistent with those described in Note 2. Summary of Significant Accounting Policies in the Fiscal 2014 Form 10-K. The Company has allocated $165.3 million, $45.3 million and $32.6 million of its recorded goodwill to the retail, direct and manufacturing segments, respectively. The Company does not have identifiable assets separated by segment, with the exception of the identifiable assets of the manufacturing segment which were $92.3 million and $96.2 million as of September 26, 2015 and December 27, 2014, respectively. Capital expenditures for the manufacturing segment for the nine months ended September 26, 2015 were approximately $3.0 million. At September 26, 2015 and December 27, 2014, long lived assets of the manufacturing segment were $60.6 million and $59.9 million, respectively. The following table contains key financial information of the Company’s business segments (in thousands): Three Months Ended Nine Months Ended September 26, September 27, September 26, September 27, Net sales: Retail $ 270,213 $ 260,324 $ 836,396 $ 802,378 Direct 31,254 31,337 96,444 99,148 Manufacturing 20,693 19,933 67,185 24,947 Segment net sales 322,160 311,594 1,000,025 926,473 Elimination of intersegment revenues (8,274 ) (2,684 ) (26,966 ) (3,509 ) Net sales $ 313,886 $ 308,910 $ 973,059 $ 922,964 Income from operations: Retail $ 47,890 $ 45,919 $ 155,562 $ 154,355 Direct 5,324 4,931 15,976 17,716 Manufacturing (1) (222 ) (2,141 ) (1,433 ) (3,012 ) Corporate costs (2) (29,635 ) (28,160 ) (92,229 ) (86,097 ) Income from operations $ 23,357 $ 20,549 $ 77,876 $ 82,962 (1) Manufacturing loss from operations for the nine months ended September 26, 2015 includes a $1.4 million charge for accounts receivable for one wholesale customer which were deemed uncollectible. Manufacturing loss from operations for the three and nine months ended September 27, 2014 includes charges from adjusting Nutri-Force inventory to fair value as part of purchase accounting of $3.3 million and $4.5 million, respectively. (2) Corporate costs include (in thousands): Three Months Ended Nine Months Ended September 26, September 27, September 26, September 27, Depreciation and amortization expenses $ 9,323 $ 8,305 $ 27,359 $ 24,478 Reinvention costs (a) 1,026 — 1,026 — Acquisition and integration costs 617 289 1,387 4,295 Management realignment charges (b) — — 2,174 — (a) During the second quarter of Fiscal 2015, the Company launched a comprehensive initiative to review and improve its customers’ experience across its retail and e-commerce channels. The costs incurred represent outside consultants fees. (b) During the second quarter of Fiscal 2015, the Company incurred management realignment charges, which primarily consisted of severance costs.

Inventories (Tables)

Inventories (Tables)	9 Months Ended
	Sep. 26, 2015
Inventory Disclosure [Abstract]
Components of Inventories	The components of inventories are as follows (in thousands): September 26, December 27, Finished goods $ 197,145 $ 171,896 Work-in-process 7,126 4,592 Raw materials 13,825 10,539 $ 218,096 $ 187,027

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	9 Months Ended
	Sep. 26, 2015
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets	The following table discloses the carrying value of all intangible assets (in thousands): September 26, 2015 December 27, 2014 Gross Accumulated Net Gross Accumulated Net Intangible assets Goodwill $ 243,269 $ — $ 243,269 $ 243,269 $ — $ 243,269 Tradenames – Indefinite-lived 68,405 — 68,405 68,405 — 68,405 Brands 10,000 741 9,259 10,000 324 9,676 Customer relationships 7,500 500 7,000 7,500 219 7,281 Tradenames – Definite-lived 4,693 2,486 2,207 4,250 1,735 2,515 Software 1,300 347 953 1,300 152 1,148 Intangibles related to asset purchase — — — 2,950 2,950 — $ 335,167 $ 4,074 $ 331,093 $ 337,674 $ 5,380 $ 332,294
Expected Amortization Expense on Definite-Lived Intangible Assets	The expected amortization expense on definite-lived intangible assets on the Company’s condensed consolidated balance sheet at September 26, 2015, is as follows (in thousands): Remainder of Fiscal 2015 $ 555 Fiscal 2016 1,515 Fiscal 2017 1,420 Fiscal 2018 1,420 Fiscal 2019 1,265 Thereafter 13,244 $ 19,419

Accrued Expenses and Other Cu21

Accrued Expenses and Other Current Liabilities (Tables)	9 Months Ended
	Sep. 26, 2015
Payables and Accruals [Abstract]
Accrued Expenses and Other Current Liabilities	Accrued expenses and other current liabilities consist of the following (in thousands): September 26, December 27, Deferred sales $ 16,909 $ 22,499 Accrued salaries and related expenses (1) 11,109 8,824 Sales tax payable and related expenses 7,453 6,494 Accrued fixed asset additions 5,052 7,290 Other accrued expenses 24,974 30,713 $ 65,497 $ 75,820 (1) Accrued salaries and related expenses as of September 26, 2015 includes $1.2 million related to accrued employee severance.

Credit Arrangements (Tables)

Credit Arrangements (Tables)	9 Months Ended
	Sep. 26, 2015
Debt Disclosure [Abstract]
Interest Expense, Net	Interest expense, net for the three and nine months ended September 26, 2015 and September 27, 2014 consists of the following (in thousands): Three Months Ended Nine Months Ended September 26, September 27, September 26, September 27, Fees on the revolving credit facility and interest $ 110 $ 103 $ 375 $ 234 Amortization of deferred financing fees 62 37 141 104 Interest income — — (1 ) (13 ) Interest expense, net $ 172 $ 140 $ 515 $ 325

Stock Based Compensation (Table

Stock Based Compensation (Tables)	9 Months Ended
	Sep. 26, 2015
Summary of Stock Options	The following table summarizes stock options for the 2006 and 2009 Plans as of September 26, 2015 and changes during the nine month period then ended: Number Weighted Weighted Aggregate Outstanding at December 27, 2014 383,577 $ 24.14 Granted — — Exercised (56,338 ) $ 23.93 Canceled/forfeited (39,792 ) $ 34.43 Outstanding at September 26, 2015 287,447 $ 22.75 3.14 $ 3,442 Vested or expected to vest at September 26, 2015 287,165 $ 22.75 3.14 Vested and exercisable at September 26, 2015 284,630 $ 22.45 3.10 $ 3,442
Summary of Fair Value Option Grant Using Black-Scholes Option-Pricing Model	The fair value of each option grant was estimated on the date of grant using the Black-Scholes option-pricing model with the following assumptions: Three Months Ended Nine Months Ended September 27, 2014 September 27, 2014 Expected dividend yield 0.0 % 0.0 % Weighted average expected volatility 33.3 % 35.3 % Weighted average risk-free interest rate 1.4 % 1.4 % Expected holding period 4.00 years 4.00 - 4.43 years
Restricted Shares [Member]
Summary of Restricted Shares	The following table summarizes restricted shares for the 2009 Plan as of September 26, 2015 and changes during the nine month period then ended: Number of Unvested Weighted Unvested at December 27, 2014 448,611 $ 45.04 Granted 220,831 $ 40.71 Vested (153,493 ) $ 42.95 Canceled/forfeited (116,778 ) $ 45.09 Unvested at September 26, 2015 399,171 $ 43.43
Restricted Share Units [Member]
Summary of Restricted Shares	The following table summarizes restricted share units for the 2009 Plan as of September 26, 2015 and changes during the nine month period then ended: Number of Unvested Weighted Unvested at December 27, 2014 9,633 $ 51.37 Granted 20,747 $ 39.99 Vested (14,995 ) $ 49.99 Canceled/forfeited — — Unvested at September 26, 2015 15,385 $ 37.37

Net Income Per Share (Tables)

Net Income Per Share (Tables)	9 Months Ended
	Sep. 26, 2015
Earnings Per Share [Abstract]
Calculation of Basic and Diluted Net Income Per Common Share	The components of the calculation of basic net income per common share and diluted net income per common share are as follows (in thousands except share and per share data): Three Months Ended Nine Months Ended September 26, September 27, September 26, September 27, Numerator: Net income $ 14,098 $ 12,197 $ 47,039 $ 49,632 Denominator: Basic weighted average common shares outstanding 28,988,779 30,332,506 29,238,808 30,327,800 Effect of dilutive securities: Stock options 86,627 207,871 103,885 261,996 Restricted shares 113,535 164,355 160,252 174,515 Restricted share units 1,513 5,832 1,473 3,543 Diluted weighted average common shares outstanding 29,190,454 30,710,564 29,504,418 30,767,854 Basic net income per common share $ 0.49 $ 0.40 $ 1.61 $ 1.64 Diluted net income per common share $ 0.48 $ 0.40 $ 1.59 $ 1.61

Segment Data (Tables)

Segment Data (Tables)	9 Months Ended
	Sep. 26, 2015
Segment Reporting [Abstract]
Table of Key Financial Information of Company's Business Segments	The following table contains key financial information of the Company’s business segments (in thousands): Three Months Ended Nine Months Ended September 26, September 27, September 26, September 27, Net sales: Retail $ 270,213 $ 260,324 $ 836,396 $ 802,378 Direct 31,254 31,337 96,444 99,148 Manufacturing 20,693 19,933 67,185 24,947 Segment net sales 322,160 311,594 1,000,025 926,473 Elimination of intersegment revenues (8,274 ) (2,684 ) (26,966 ) (3,509 ) Net sales $ 313,886 $ 308,910 $ 973,059 $ 922,964 Income from operations: Retail $ 47,890 $ 45,919 $ 155,562 $ 154,355 Direct 5,324 4,931 15,976 17,716 Manufacturing (1) (222 ) (2,141 ) (1,433 ) (3,012 ) Corporate costs (2) (29,635 ) (28,160 ) (92,229 ) (86,097 ) Income from operations $ 23,357 $ 20,549 $ 77,876 $ 82,962 (1) Manufacturing loss from operations for the nine months ended September 26, 2015 includes a $1.4 million charge for accounts receivable for one wholesale customer which were deemed uncollectible. Manufacturing loss from operations for the three and nine months ended September 27, 2014 includes charges from adjusting Nutri-Force inventory to fair value as part of purchase accounting of $3.3 million and $4.5 million, respectively. (2) Corporate costs include (in thousands): Three Months Ended Nine Months Ended September 26, September 27, September 26, September 27, Depreciation and amortization expenses $ 9,323 $ 8,305 $ 27,359 $ 24,478 Reinvention costs (a) 1,026 — 1,026 — Acquisition and integration costs 617 289 1,387 4,295 Management realignment charges (b) — — 2,174 — (a) During the second quarter of Fiscal 2015, the Company launched a comprehensive initiative to review and improve its customers’ experience across its retail and e-commerce channels. The costs incurred represent outside consultants fees. (b) During the second quarter of Fiscal 2015, the Company incurred management realignment charges, which primarily consisted of severance costs.

Acquisition - Additional Inform

Acquisition - Additional Information (Detail) - FDC Vitamins, LLC [Member] - USD ($) $ in Millions	Jun. 06, 2014	Mar. 28, 2015
Business Acquisition [Line Items]
Total purchase price	$ 86.1
Contingent consideration		$ 5

Inventories - Components of Inv

Inventories - Components of Inventories (Detail) - USD ($) $ in Thousands	Sep. 26, 2015	Dec. 27, 2014
Inventory Disclosure [Abstract]
Finished goods	$ 197,145	$ 171,896
Work-in-process	7,126	4,592
Raw materials	13,825	10,539
Inventories, Total	$ 218,096	$ 187,027

Goodwill and Intangible Asset28

Goodwill and Intangible Assets - Schedule of Intangible Assets (Detail) - USD ($) $ in Thousands	Sep. 26, 2015	Dec. 27, 2014
Schedule Of Goodwill And Other Intangible Assets [Line Items]
Intangible Assets, Goodwill, Gross Carrying Amount	$ 243,269	$ 243,269
Goodwill	243,269	243,269
Intangible Assets, Gross Carrying Amount	335,167	337,674
Intangible Assets, Accumulated Amortization	4,074	5,380
Goodwill and Intangible Assets, Net	331,093	332,294
Finite-Lived Intangible Assets, Amortization Expense	19,419
Intangible Assets, Net	87,824	89,025
Intangibles Related to Asset Purchase [Member]
Schedule Of Goodwill And Other Intangible Assets [Line Items]
Intangible Assets, Definite - Lived, Gross Carrying Amount		2,950
Intangible Assets, Accumulated Amortization		2,950
Intangible Assets, Net	0	0
Brands [Member]
Schedule Of Goodwill And Other Intangible Assets [Line Items]
Intangible Assets, Definite - Lived, Gross Carrying Amount	10,000	10,000
Intangible Assets, Accumulated Amortization	741	324
Finite-Lived Intangible Assets, Amortization Expense	9,259	9,676
Customer Relationships [Member]
Schedule Of Goodwill And Other Intangible Assets [Line Items]
Intangible Assets, Definite - Lived, Gross Carrying Amount	7,500	7,500
Intangible Assets, Accumulated Amortization	500	219
Finite-Lived Intangible Assets, Amortization Expense	7,000	7,281
Tradenames [Member]
Schedule Of Goodwill And Other Intangible Assets [Line Items]
Intangible Assets, Definite - Lived, Gross Carrying Amount	4,693	4,250
Intangible Assets, Tradenames-Indefinite-Lived, Gross Carrying Amount	68,405	68,405
Intangible Assets, Tradenames-Indefinite-Lived, Net	68,405	68,405
Intangible Assets, Accumulated Amortization	2,486	1,735
Finite-Lived Intangible Assets, Amortization Expense	2,207	2,515
Software [Member]
Schedule Of Goodwill And Other Intangible Assets [Line Items]
Intangible Assets, Definite - Lived, Gross Carrying Amount	1,300	1,300
Intangible Assets, Accumulated Amortization	347	152
Finite-Lived Intangible Assets, Amortization Expense	$ 953	$ 1,148

Goodwill and Intangible Asset29

Goodwill and Intangible Assets - Additional Information (Detail)	9 Months Ended
	Sep. 26, 2015
Minimum [Member]
Goodwill And Intangible Assets [Line Items]
Useful lives of definite-lived intangible assets, years	3 years
Maximum [Member]
Goodwill And Intangible Assets [Line Items]
Useful lives of definite-lived intangible assets, years	20 years

Goodwill and Intangible Asset30

Goodwill and Intangible Assets - Expected Amortization Expense on Definite-Lived Intangible Assets (Detail) $ in Thousands	Sep. 26, 2015USD ($)
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Remainder of Fiscal 2015	$ 555
Fiscal 2,016	1,515
Fiscal 2,017	1,420
Fiscal 2,018	1,420
Fiscal 2,019	1,265
Thereafter	13,244
Finite-Lived Intangible Assets, Amortization Expense	$ 19,419

Accrued Expenses and Other Cu31

Accrued Expenses and Other Current Liabilities - Accrued Expenses and Other Current Liabilities (Detail) - USD ($) $ in Thousands	Sep. 26, 2015	Dec. 27, 2014
Payables and Accruals [Abstract]
Deferred sales	$ 16,909	$ 22,499
Accrued salaries and related expenses	11,109	8,824
Sales tax payable and related expenses	7,453	6,494
Accrued fixed asset additions	5,052	7,290
Other accrued expenses	24,974	30,713
Accrued expenses and other current liabilities	$ 65,497	$ 75,820

Accrued Expenses and Other Cu32

Accrued Expenses and Other Current Liabilities - Accrued Expenses and Other Current Liabilities (Parenthetical) (Detail) $ in Millions	Sep. 26, 2015USD ($)
Payables and Accruals [Abstract]
Accrued employee severance costs	$ 1.2

Credit Arrangements - Additiona

Credit Arrangements - Additional Information (Detail) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 26, 2015	Dec. 27, 2014	Sep. 27, 2014
Debt Instrument [Line Items]
Outstanding debt	$ 8,000,000	$ 8,000,000
Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Outstanding debt	8,000,000	$ 8,000,000
Revolving Credit Facility, current borrowing capacity	90,000,000
Revolving Credit Facility, maximum borrowing capacity	$ 150,000,000
Revolving Credit Facility, maturity date	Oct. 11, 2018
Borrowings under Revolving Credit Facility	$ 27,000,000		$ 0
Revolving Credit Facility, unused available line of credit	$ 79,200,000
Revolving Credit Facility, interest rate description	Borrowings under the Revolving Credit Facility accrue interest, at the Company's option, at the rate per annum based on an "alternative base rate" plus 0.25% or 0.50% or the adjusted Eurodollar rate plus 1.25% or 1.50%, in each case with the higher spread applicable in the event that the aggregate amount of the borrowings under the Revolving Credit Facility exceeds 50% of the borrowing base availability under the Revolving Credit Facility.
Percentage of aggregate borrowings facility limit	50.00%
Weighted average interest rate	1.44%
Percentage of commitment fee on undrawn portion of Revolving Credit Facility	0.25%	0.25%
Minimum [Member] | Revolving Credit Facility [Member] | Alternative Base Rate [Member]
Debt Instrument [Line Items]
Variable interest rate, basis spread	0.25%
Minimum [Member] | Revolving Credit Facility [Member] | Adjusted Eurodollar Rate [Member]
Debt Instrument [Line Items]
Variable interest rate, basis spread	1.25%
Maximum [Member] | Revolving Credit Facility [Member] | Alternative Base Rate [Member]
Debt Instrument [Line Items]
Variable interest rate, basis spread	0.50%
Maximum [Member] | Revolving Credit Facility [Member] | Adjusted Eurodollar Rate [Member]
Debt Instrument [Line Items]
Variable interest rate, basis spread	1.50%

Credit Arrangements - Interest

Credit Arrangements - Interest Expense, Net (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 26, 2015	Sep. 27, 2014	Sep. 26, 2015	Sep. 27, 2014
Debt Instrument [Line Items]
Amortization of deferred financing fees	$ 62	$ 37	$ 141	$ 104
Interest income			(1)	(13)
Interest expense, net	172	140	515	325
Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Fees on the revolving credit facility and interest	$ 110	$ 103	$ 375	$ 234

Stock Based Compensation - Addi

Stock Based Compensation - Additional Information (Detail) $ / shares in Units, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 26, 2015USD ($)shares	Sep. 27, 2014USD ($)$ / shares	Sep. 26, 2015USD ($)Planshares	Sep. 27, 2014USD ($)$ / shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of equity incentive plans | Plan			2
Intrinsic value of options exercised			$ 1	$ 13.3
Cash received from options exercised			1.3	6.7
Compensation expense attributable to stock-based compensation	$ 1.2	$ 2	4.7	$ 5.8
Remaining unrecognized stock based compensation expense for non-vested stock options, restricted shares and restricted shares units to be expensed in future periods	9.6		$ 9.6
Weighted average recognition period for non-vested stock options, restricted shares and restricted shares units			1 year 8 months 12 days
Estimated value of future forfeitures for stock options, restricted shares and restricted share units	$ 0.9		$ 0.9
Weighted-average grant date fair value for stock options | $ / shares		$ 9.63		$ 18.99
Treasury stock purchased in settlement of employees' tax obligations, shares | shares			61,515
Treasury stock purchased in settlement of employees' tax obligations, value			$ 2.5
2006 and 2009 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available to grant under both plans | shares	2,369,021		2,369,021
Restricted Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Intrinsic value of restricted shares vested			$ 6.2	$ 5.3
Restricted Share Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Intrinsic value of restricted shares vested			$ 0.5	$ 0.3

Stock Based Compensation - Summ

Stock Based Compensation - Summary of Restricted Shares (Detail)	9 Months Ended
	Sep. 26, 2015$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unvested at December 27, 2014, Number of Unvested Restricted Shares | shares	448,611
Granted, Number of Unvested Restricted Shares | shares	220,831
Vested, Number of Unvested Restricted Shares | shares	(153,493)
Canceled/forfeited, Number of Unvested Restricted Shares | shares	(116,778)
Unvested at September 26, 2015, Number of Unvested Restricted Shares | shares	399,171
Unvested at December 27, 2014, Weighted Average Grant Date Fair Value	$ 45.04
Granted, Weighted Average Grant Date Fair Value	40.71
Vested, Weighted Average Grant Date Fair Value	42.95
Canceled/forfeited, Weighted Average Grant Date Fair Value	45.09
Unvested at September 26, 2015, Weighted Average Grant Date Fair Value	$ 43.43
Restricted Share Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unvested at December 27, 2014, Number of Unvested Restricted Shares | shares	9,633
Granted, Number of Unvested Restricted Shares | shares	20,747
Vested, Number of Unvested Restricted Shares | shares	(14,995)
Unvested at September 26, 2015, Number of Unvested Restricted Shares | shares	15,385
Unvested at December 27, 2014, Weighted Average Grant Date Fair Value	$ 51.37
Granted, Weighted Average Grant Date Fair Value	39.99
Vested, Weighted Average Grant Date Fair Value	49.99
Unvested at September 26, 2015, Weighted Average Grant Date Fair Value	$ 37.37

Stock Based Compensation - Su37

Stock Based Compensation - Summary of Stock Options (Detail) $ / shares in Units, $ in Thousands	9 Months Ended
	Sep. 26, 2015USD ($)$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest [Abstract]
Outstanding at December 27, 2014, Number of Options | shares	383,577
Granted, Number of Options | shares	0
Exercised, Number of Options | shares	(56,338)
Canceled/forfeited, Number of Options | shares	(39,792)
Outstanding at September 26, 2015, Number of Options | shares	287,447
Vested or expected to vest at September 26, 2015, Number of Options | shares	287,165
Vested and exercisable at September 26, 2015, Number of Options | shares	284,630
Outstanding at December 27, 2014, Weighted Average Exercise Price	$ 24.14
Granted, Weighted Average Exercise Price	0
Exercised, Weighted Average Exercise Price	23.93
Canceled/forfeited, Weighted Average Exercise Price	34.43
Outstanding at September 26, 2015, Weighted Average Exercise Price	22.75
Vested or expected to vest at September 26, 2015, Weighted Average Exercise Price	22.75
Vested and exercisable at September 26, 2015, Weighted Average Exercise Price	$ 22.45
Outstanding at September 26, 2015, Weighted Average Remaining Contractual Life (years)	3 years 1 month 21 days
Vested or expected to vest at September 26, 2015, Weighted Average Remaining Contractual Life (years)	3 years 1 month 21 days
Vested and exercisable at September 26, 2015, Weighted Average Remaining Contractual Life (years)	3 years 1 month 6 days
Outstanding at September 26, 2015, Aggregate Intrinsic Value | $	$ 3,442
Vested or expected to vest at September 26, 2015, Aggregate Intrinsic Value | $	0
Vested and exercisable at September 26, 2015, Aggregate Intrinsic Value | $	$ 3,442

Stock Based Compensation - Su38

Stock Based Compensation - Summary of Fair Value Option Grant Using Black-Scholes Option-Pricing Model (Detail)	3 Months Ended	9 Months Ended
	Sep. 27, 2014	Sep. 27, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected dividend yield	0.00%	0.00%
Weighted average expected volatility	33.30%	35.30%
Weighted average risk-free interest rate	1.40%	1.40%
Expected holding period	4 years
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected holding period		4 years
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected holding period		4 years 5 months 5 days

Advertising Costs - Additional

Advertising Costs - Additional Information (Detail) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 26, 2015	Sep. 27, 2014	Sep. 26, 2015	Sep. 27, 2014
Other Income and Expenses [Abstract]
Advertising expense	$ 5.3	$ 5.3	$ 16.8	$ 15.3

Net Income Per Share - Calculat

Net Income Per Share - Calculation of Basic and Diluted Net Income Per Common Share (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 26, 2015	Sep. 27, 2014	Sep. 26, 2015	Sep. 27, 2014
Summary Of Computation Of Basic And Diluted Earnings Per Share [Line Items]
Net income	$ 14,098	$ 12,197	$ 47,039	$ 49,632
Basic weighted average common shares outstanding	28,988,779	30,332,506	29,238,808	30,327,800
Diluted weighted average common shares outstanding	29,190,454	30,710,564	29,504,418	30,767,854
Basic net income per common share	$ 0.49	$ 0.40	$ 1.61	$ 1.64
Diluted net income per common share	$ 0.48	$ 0.40	$ 1.59	$ 1.61
Stock Options [Member]
Summary Of Computation Of Basic And Diluted Earnings Per Share [Line Items]
Effect of dilutive securities	86,627	207,871	103,885	261,996
Restricted Shares [Member]
Summary Of Computation Of Basic And Diluted Earnings Per Share [Line Items]
Effect of dilutive securities	113,535	164,355	160,252	174,515
Restricted Share Units [Member]
Summary Of Computation Of Basic And Diluted Earnings Per Share [Line Items]
Effect of dilutive securities	1,513	5,832	1,473	3,543

Net Income Per Share - Addition

Net Income Per Share - Additional Information (Detail) - shares	3 Months Ended		9 Months Ended
	Sep. 26, 2015	Sep. 27, 2014	Sep. 26, 2015	Sep. 27, 2014
Stock Options [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities excluded from computation of earnings per share	90,737	8,355	34,803	17,450
Restricted Shares [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities excluded from computation of earnings per share	90,737	8,355	34,803	17,450

Share Repurchase Programs - Add

Share Repurchase Programs - Additional Information (Detail) - USD ($)	Sep. 26, 2015	May. 06, 2015	Aug. 05, 2014	Sep. 26, 2015	Sep. 26, 2015
Equity, Class of Treasury Stock [Line Items]
Purchase of common stock under share repurchase programs		$ 200,000,000
Common stock shares repurchased and retired during period, shares				355,021	981,353
Common stock shares repurchased and retired during period, value				$ 12,400,000	$ 38,000,000
Common stock shares repurchased price per share				$ 35	$ 38.69
Common Stock [Member]
Equity, Class of Treasury Stock [Line Items]
Common stock shares repurchased and retired during period, shares	2,253,392
Additional Paid-In Capital [Member]
Equity, Class of Treasury Stock [Line Items]
Common stock shares repurchased and retired during period, value	$ 95,800,000
August 5, 2014 Share Repurchase Program [Member]
Equity, Class of Treasury Stock [Line Items]
Purchase of common stock under share repurchase programs			$ 100,000,000
Stock repurchase program, period in force			3 years
Stock repurchase program expiration date					Aug. 4, 2017
May 6, 2015 Share Repurchase Program [Member]
Equity, Class of Treasury Stock [Line Items]
Purchase of common stock under share repurchase programs		$ 100,000,000
Stock repurchase program, period in force		3 years
Stock repurchase program expiration date					May 5, 2018

Segment Data - Additional Infor

Segment Data - Additional Information (Detail) $ in Thousands	9 Months Ended
	Sep. 26, 2015USD ($)SegmentStock_Unit	Sep. 27, 2014USD ($)	Dec. 27, 2014USD ($)
Segment Reporting Information [Line Items]
Number of business segments | Segment	3
Number of SKUs available for online access | Stock_Unit	21,500
Goodwill	$ 243,269		$ 243,269
Identifiable assets	736,264		722,391
Capital expenditures	30,172	$ 30,801
Retail [Member]
Segment Reporting Information [Line Items]
Goodwill	165,300
Direct [Member]
Segment Reporting Information [Line Items]
Goodwill	45,300
Manufacturing [Member]
Segment Reporting Information [Line Items]
Goodwill	32,600
Identifiable assets	92,300		96,200
Capital expenditures	3,000
Long lived assets	$ 60,600		$ 59,900

Segment Data - Table of Key Fin

Segment Data - Table of Key Financial Information of Company's Business Segments (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 26, 2015	Sep. 27, 2014	Sep. 26, 2015	Sep. 27, 2014
Revenue from External Customer [Line Items]
Net sales	$ 313,886	$ 308,910	$ 973,059	$ 922,964
Income from operations	23,357	20,549	77,876	82,962
Operating Segments [Member]
Revenue from External Customer [Line Items]
Net sales	322,160	311,594	1,000,025	926,473
Operating Segments [Member] | Retail [Member]
Revenue from External Customer [Line Items]
Net sales	270,213	260,324	836,396	802,378
Income from operations	47,890	45,919	155,562	154,355
Operating Segments [Member] | Direct [Member]
Revenue from External Customer [Line Items]
Net sales	31,254	31,337	96,444	99,148
Income from operations	5,324	4,931	15,976	17,716
Operating Segments [Member] | Manufacturing [Member]
Revenue from External Customer [Line Items]
Net sales	20,693	19,933	67,185	24,947
Income from operations	(222)	(2,141)	(1,433)	(3,012)
Elimination of Intercompany Revenues [Member]
Revenue from External Customer [Line Items]
Net sales	(8,274)	(2,684)	(26,966)	(3,509)
Corporate Costs [Member]
Revenue from External Customer [Line Items]
Income from operations	$ (29,635)	$ (28,160)	$ (92,229)	$ (86,097)

Segment Data - Table of Key F45

Segment Data - Table of Key Financial Information of Company's Business Segments (Parenthetical) (Detail) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 26, 2015USD ($)	Sep. 27, 2014USD ($)	Sep. 26, 2015USD ($)Customer	Sep. 27, 2014USD ($)
Revenue from External Customer [Line Items]
Depreciation and amortization expenses			$ 28,457	$ 25,060
Corporate Costs [Member]
Revenue from External Customer [Line Items]
Depreciation and amortization expenses	$ 9,323	$ 8,305	27,359	24,478
Reinvention costs	1,026		1,026
Acquisition and integration costs	$ 617	289	1,387	4,295
Management realignment charges			2,174
Manufacturing [Member] | Operating Segments [Member] | Nutri-Force [Member]
Revenue from External Customer [Line Items]
Adjustment of inventory to fair value		$ 3,300		$ 4,500
Manufacturing [Member] | Operating Segments [Member] | Accounts Receivable [Member]
Revenue from External Customer [Line Items]
Allowance for doubtful accounts charge			$ 1,400
Number of wholesale customers | Customer			1